General Information of Drug (ID: DMGXTOP)

Drug Name
JTX-2011 Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMGXTOP

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
KY1044 DMXJ683 Solid tumour/cancer 2A00-2F9Z Phase 1/2 [2]
XmAb23104 DMK9XUQ Solid tumour/cancer 2A00-2F9Z Phase 1 [3]
MEDI-570 DMCJFLS Systemic lupus erythematosus 4A40.0 Phase 1 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Inducible T-cell costimulator (ICOS) TTE5VP6 ICOS_HUMAN Agonist [1]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of Kymab.
3 Clinical pipeline report, company report or official report of Xencor.
4 B-cell targeted therapeutics in clinical development. Arthritis Res Ther. 2013;15 Suppl 1:S4.